Contact
searchSearch
HMP Global

Drug Recalls

The Latest

News
Clomiphene Citrate Recalled Due to CGMP Deviations
07/16/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for clomiphene citrate due to Current Good Manufacturing Practice (CGMP) deviations.
The US Food and Drug Administration (FDA) has issued a Class II recall for clomiphene citrate due to Current Good Manufacturing Practice (CGMP) deviations.
The US Food and Drug...
07/16/2026
Pharmacy Learning Network
News
Bortezomib Injections Recalled Due to Lack of Sterility Assurance
07/16/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for bortezomib injections due to a lack of sterility assurance, affecting 11 400 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for bortezomib injections due to a lack of sterility assurance, affecting 11 400 vials.
The US Food and Drug...
07/16/2026
Pharmacy Learning Network
News
Methohexital Sodium Injections Recalled Due to Failed Impurities/Degradation Specifications
07/16/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for methohexital sodium injections due to the product’s failure to meet impurities/degradation specifications, affecting 4284 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for methohexital sodium injections due to the product’s failure to meet impurities/degradation specifications, affecting 4284 vials.
The US Food and Drug...
07/16/2026
Pharmacy Learning Network
News
ADHD Medication Recalled Due to Incorrect Labeling
07/09/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for combination extended-release capsules of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate due to a...
The US Food and Drug Administration (FDA) has issued a Class II recall for combination extended-release capsules of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate due to a...
The US Food and Drug...
07/09/2026
Pharmacy Learning Network
News
Synjardy XR Tablets Recalled Due to CGMP Deviations
07/09/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for Synjardy XR (empagliflozin and metformin hydrochloride) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 560 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for Synjardy XR (empagliflozin and metformin hydrochloride) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 560 bottles.
The US Food and Drug...
07/09/2026
Pharmacy Learning Network
News
Imuldosa Injections Recalled Due to Lack of Sterility Assurance
07/09/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for Imuldosa (ustekinumab-srlf) injections due to a lack of sterility assurance, affecting 326 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for Imuldosa (ustekinumab-srlf) injections due to a lack of sterility assurance, affecting 326 vials.
The US Food and Drug...
07/09/2026
Pharmacy Learning Network
News
Lacosamide Tablets Recalled Due to the Presence of Foreign Tablets
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
Cinacalcet Tablets Recalled Due to CGMP Deviations
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
BD ChloraPrep Clear and BD ChloraPrep FREPP Clear Recalled Due to Non-Sterility
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for BD ChloraPrep Clear and BD ChloraPrep FREPP Clear due to non-sterility, affecting 371 440 applicators.
The US Food and Drug Administration (FDA) has issued a Class I recall for BD ChloraPrep Clear and BD ChloraPrep FREPP Clear due to non-sterility, affecting 371 440 applicators.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
Focalin XR Recalled Due to Incorrect Labeling
06/25/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for Focalin XR (dexmethylphenidate HCl) due to incorrect labeling, affecting 7803 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for Focalin XR (dexmethylphenidate HCl) due to incorrect labeling, affecting 7803 bottles.
The US Food and Drug...
06/25/2026
Pharmacy Learning Network
News
Chlorthalidone Tablets Recalled Due to Failed Dissolution Specifications
06/25/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for chlorthalidone tablets due to the product’s failure to meet dissolution specifications, affecting 11 460 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for chlorthalidone tablets due to the product’s failure to meet dissolution specifications, affecting 11 460 bottles.
The US Food and Drug...
06/25/2026
Pharmacy Learning Network

Newsfeed

News
Clomiphene Citrate Recalled Due to CGMP Deviations
07/16/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for clomiphene citrate due to Current Good Manufacturing Practice (CGMP) deviations.
The US Food and Drug Administration (FDA) has issued a Class II recall for clomiphene citrate due to Current Good Manufacturing Practice (CGMP) deviations.
The US Food and Drug...
07/16/2026
Pharmacy Learning Network
News
Bortezomib Injections Recalled Due to Lack of Sterility Assurance
07/16/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for bortezomib injections due to a lack of sterility assurance, affecting 11 400 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for bortezomib injections due to a lack of sterility assurance, affecting 11 400 vials.
The US Food and Drug...
07/16/2026
Pharmacy Learning Network
News
Methohexital Sodium Injections Recalled Due to Failed Impurities/Degradation Specifications
07/16/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for methohexital sodium injections due to the product’s failure to meet impurities/degradation specifications, affecting 4284 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for methohexital sodium injections due to the product’s failure to meet impurities/degradation specifications, affecting 4284 vials.
The US Food and Drug...
07/16/2026
Pharmacy Learning Network
News
ADHD Medication Recalled Due to Incorrect Labeling
07/09/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for combination extended-release capsules of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate due to a...
The US Food and Drug Administration (FDA) has issued a Class II recall for combination extended-release capsules of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate due to a...
The US Food and Drug...
07/09/2026
Pharmacy Learning Network
News
Synjardy XR Tablets Recalled Due to CGMP Deviations
07/09/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for Synjardy XR (empagliflozin and metformin hydrochloride) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 560 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for Synjardy XR (empagliflozin and metformin hydrochloride) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 560 bottles.
The US Food and Drug...
07/09/2026
Pharmacy Learning Network
News
Imuldosa Injections Recalled Due to Lack of Sterility Assurance
07/09/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for Imuldosa (ustekinumab-srlf) injections due to a lack of sterility assurance, affecting 326 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for Imuldosa (ustekinumab-srlf) injections due to a lack of sterility assurance, affecting 326 vials.
The US Food and Drug...
07/09/2026
Pharmacy Learning Network
News
Lacosamide Tablets Recalled Due to the Presence of Foreign Tablets
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
Cinacalcet Tablets Recalled Due to CGMP Deviations
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
BD ChloraPrep Clear and BD ChloraPrep FREPP Clear Recalled Due to Non-Sterility
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for BD ChloraPrep Clear and BD ChloraPrep FREPP Clear due to non-sterility, affecting 371 440 applicators.
The US Food and Drug Administration (FDA) has issued a Class I recall for BD ChloraPrep Clear and BD ChloraPrep FREPP Clear due to non-sterility, affecting 371 440 applicators.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
Primidone Tablets Recalled Due to Cross Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
Clomiphene Citrate Recalled Due to CGMP Deviations
07/16/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for clomiphene citrate due to Current Good Manufacturing Practice (CGMP) deviations.
The US Food and Drug Administration (FDA) has issued a Class II recall for clomiphene citrate due to Current Good Manufacturing Practice (CGMP) deviations.
The US Food and Drug...
07/16/2026
Pharmacy Learning Network
News
Bortezomib Injections Recalled Due to Lack of Sterility Assurance
07/16/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for bortezomib injections due to a lack of sterility assurance, affecting 11 400 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for bortezomib injections due to a lack of sterility assurance, affecting 11 400 vials.
The US Food and Drug...
07/16/2026
Pharmacy Learning Network
News
Methohexital Sodium Injections Recalled Due to Failed Impurities/Degradation Specifications
07/16/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for methohexital sodium injections due to the product’s failure to meet impurities/degradation specifications, affecting 4284 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for methohexital sodium injections due to the product’s failure to meet impurities/degradation specifications, affecting 4284 vials.
The US Food and Drug...
07/16/2026
Pharmacy Learning Network
PharmLaw
FTC Settlement With Caremark Signals New Compliance Expectations for PBMs
07/15/2026
Hannah Musick
The Federal Trade Commission's (FTC) proposed settlement with CVS Caremark would require significant changes to pharmacy benefit manager (PBM) rebate practices, transparency, formulary management, and pharmacy contracting, signaling evolving...
The Federal Trade Commission's (FTC) proposed settlement with CVS Caremark would require significant changes to pharmacy benefit manager (PBM) rebate practices, transparency, formulary management, and pharmacy contracting, signaling evolving...
The Federal Trade Commission's...
07/15/2026
Pharmacy Learning Network
News
ADHD Medication Recalled Due to Incorrect Labeling
07/09/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for combination extended-release capsules of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate due to a...
The US Food and Drug Administration (FDA) has issued a Class II recall for combination extended-release capsules of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate due to a...
The US Food and Drug...
07/09/2026
Pharmacy Learning Network
News
Synjardy XR Tablets Recalled Due to CGMP Deviations
07/09/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for Synjardy XR (empagliflozin and metformin hydrochloride) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 560 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for Synjardy XR (empagliflozin and metformin hydrochloride) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 560 bottles.
The US Food and Drug...
07/09/2026
Pharmacy Learning Network
News
Imuldosa Injections Recalled Due to Lack of Sterility Assurance
07/09/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for Imuldosa (ustekinumab-srlf) injections due to a lack of sterility assurance, affecting 326 vials.
The US Food and Drug Administration (FDA) has issued a Class II recall for Imuldosa (ustekinumab-srlf) injections due to a lack of sterility assurance, affecting 326 vials.
The US Food and Drug...
07/09/2026
Pharmacy Learning Network
PharmLaw
Former Done Global CEO, Clinical President Sentenced in Telehealth Adderall Fraud Case
07/08/2026
Grace Taylor, MS, MA
Former executives of Done Global were sentenced to federal prison after convictions in a multimillion-dollar scheme involving unlawful telehealth prescribing of Adderall and health care fraud, according to the US Department of Justice.
Former executives of Done Global were sentenced to federal prison after convictions in a multimillion-dollar scheme involving unlawful telehealth prescribing of Adderall and health care fraud, according to the US Department of Justice.
Former executives of Done Global...
07/08/2026
Pharmacy Learning Network
News
Lacosamide Tablets Recalled Due to the Presence of Foreign Tablets
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
Cinacalcet Tablets Recalled Due to CGMP Deviations
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use